Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CD30+ Lymphoproliferative Disorders of the Skin.
Sauder MB, O'Malley JT, LeBoeuf NR. Sauder MB, et al. Among authors: leboeuf nr. Hematol Oncol Clin North Am. 2017 Apr;31(2):317-334. doi: 10.1016/j.hoc.2016.11.006. Hematol Oncol Clin North Am. 2017. PMID: 28340881 Free PMC article. Review.
Rituximab Treatment of Nivolumab-Induced Bullous Pemphigoid.
Sowerby L, Dewan AK, Granter S, Gandhi L, LeBoeuf NR. Sowerby L, et al. Among authors: leboeuf nr. JAMA Dermatol. 2017 Jun 1;153(6):603-605. doi: 10.1001/jamadermatol.2017.0091. JAMA Dermatol. 2017. PMID: 28355425 No abstract available.
Nonbullous pemphigoid secondary to PD-1 inhibition.
Singer S, Nelson CA, Lian CG, Dewan AK, LeBoeuf NR. Singer S, et al. Among authors: leboeuf nr. JAAD Case Rep. 2019 Oct 3;5(10):898-903. doi: 10.1016/j.jdcr.2019.07.015. eCollection 2019 Oct. JAAD Case Rep. 2019. PMID: 31646161 Free PMC article. No abstract available.
Bullous pemphigoid after anti-programmed death-1 therapy: A retrospective case-control study evaluating impact on tumor response and survival outcomes.
Nelson CA, Singer S, Chen T, Puleo AE, Lian CG, Wei EX, Giobbie-Hurder A, Mostaghimi A, LeBoeuf NR. Nelson CA, et al. Among authors: leboeuf nr. J Am Acad Dermatol. 2022 Dec;87(6):1400-1402. doi: 10.1016/j.jaad.2019.12.068. Epub 2020 Jan 10. J Am Acad Dermatol. 2022. PMID: 31931083 No abstract available.
Reply to: "Comment on 'Bullous pemphigoid after anti-PD-1 therapy: A retrospective case-control study evaluating impact on tumor response and survival outcomes'".
Nelson CA, Singer S, Chen T, Puleo AE, Lian CG, Wei EX, Giobbie-Hurder A, Mostaghimi A, LeBoeuf NR. Nelson CA, et al. Among authors: leboeuf nr. J Am Acad Dermatol. 2022 Dec;87(6):e245-e248. doi: 10.1016/j.jaad.2020.05.023. Epub 2020 May 15. J Am Acad Dermatol. 2022. PMID: 32417422 No abstract available.
161 results